BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29186342)

  • 1. Linking Metabolic Disease With the PGC-1α Gly482Ser Polymorphism.
    Vandenbeek R; Khan NP; Estall JL
    Endocrinology; 2018 Feb; 159(2):853-865. PubMed ID: 29186342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gly482Ser missense mutation of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects.
    Fanelli M; Filippi E; Sentinelli F; Romeo S; Fallarino M; Buzzetti R; Leonetti F; Baroni MG
    Dis Markers; 2005; 21(4):175-80. PubMed ID: 16403952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) is associated with type 2 diabetes in Tunisian population.
    Jemaa Z; Kallel A; Sleimi C; Mahjoubi I; Feki M; Ftouhi B; Slimane H; Jemaa R; Kaabachi N
    Diabetes Metab Syndr; 2015; 9(4):316-9. PubMed ID: 25470625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PGC-1alpha Gly482Ser polymorphism is associated with the plasma adiponectin level in type 2 diabetic men.
    Okauchi Y; Iwahashi H; Okita K; Yuan M; Matsuda M; Tanaka T; Miyagawa J; Funahashi T; Horikawa Y; Shimomura I; Yamagata K
    Endocr J; 2008 Dec; 55(6):991-7. PubMed ID: 18614852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome.
    Ambye L; Rasmussen S; Fenger M; Jørgensen T; Borch-Johnsen K; Madsbad S; Urhammer SA
    Diabetes Res Clin Pract; 2005 Feb; 67(2):175-9. PubMed ID: 15649578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of PGC-1α gene with type 2 diabetes in three unrelated endogamous groups of North-West India (Punjab): a case-control and meta-analysis study.
    Sharma R; Matharoo K; Kapoor R; Bhanwer AJS
    Mol Genet Genomics; 2018 Apr; 293(2):317-329. PubMed ID: 29063962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians.
    Muller YL; Bogardus C; Pedersen O; Baier L
    Diabetes; 2003 Mar; 52(3):895-8. PubMed ID: 12606537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) on mitochondrial transcription factor A (Tfam) promoter.
    Choi YS; Hong JM; Lim S; Ko KS; Pak YK
    Biochem Biophys Res Commun; 2006 Jun; 344(3):708-12. PubMed ID: 16631115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of obesity associated with the variant allele of the PPARGC1A Gly482Ser polymorphism in physically inactive elderly men.
    Ridderstråle M; Johansson LE; Rastam L; Lindblad U
    Diabetologia; 2006 Mar; 49(3):496-500. PubMed ID: 16474966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes.
    Barroso I; Luan J; Sandhu MS; Franks PW; Crowley V; Schafer AJ; O'Rahilly S; Wareham NJ
    Diabetologia; 2006 Mar; 49(3):501-5. PubMed ID: 16435105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered allele substitution at PPARGC1A rs8192678 alters human white adipocyte differentiation, lipogenesis, and PGC-1α content and turnover.
    Huang M; Claussnitzer M; Saadat A; Coral DE; Kalamajski S; Franks PW
    Diabetologia; 2023 Jul; 66(7):1289-1305. PubMed ID: 37171500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gly482Ser polymorphism of the coactivator-1alpha of the activated receptor of peroxisome gamma proliferation in individuals from Maracaibo, Venezuela].
    Zambrano M; Fernández E; López M; Rangel A; de Romero P; Fernández V; Marina Morales L; Molero-Conejo E; Connell L; Raleigh X; Aranguren-Mendez J
    Invest Clin; 2009 Sep; 50(3):285-94. PubMed ID: 19961051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between PPARGC1A single nucleotide polymorphisms and increased risk of nonalcoholic fatty liver disease among Iranian patients with type 2 diabetes mellitus.
    Saremi L; Lotfıpanah S; Mohammadi M; Hosseinzadeh H; Hosseini-Khah Z; Johari B; Saltanatpour Z
    Turk J Med Sci; 2019 Aug; 49(4):1089-1094. PubMed ID: 31390852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between peroxisome proliferator-activated receptor-gamma coactivator-1alpha gene polymorphisms and type 2 diabetes in southern Chinese population: role of altered interaction with myocyte enhancer factor 2C.
    Zhang SL; Lu WS; Yan L; Wu MC; Xu MT; Chen LH; Cheng H
    Chin Med J (Engl); 2007 Nov; 120(21):1878-85. PubMed ID: 18067759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.
    Andrulionytè L; Zacharova J; Chiasson JL; Laakso M;
    Diabetologia; 2004 Dec; 47(12):2176-84. PubMed ID: 15592662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of ethnicity in the association of WC, WHR, hypertension and PGC-1α (Gly482Ser), UCP2 -866 G/A and SIRT1 -1400 T/C polymorphisms with T2D in the population of Punjab.
    Kaul N; Singh YP; Bhanwer AJ
    Gene; 2015 Jun; 563(2):150-4. PubMed ID: 25773007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Meta-analysis Revealed an Association of PGC-1
    Xia W; Chen N; Peng W; Jia X; Yu Y; Wu X; Gao H
    Dis Markers; 2019; 2019():2970401. PubMed ID: 30944665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Andrulionyte L; Peltola P; Chiasson JL; Laakso M;
    Diabetes; 2006 Jul; 55(7):2148-52. PubMed ID: 16804087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of PGC-1alpha variants Gly482Ser and Thr612Met concerning their PPARgamma2-coactivation function.
    Nitz I; Ewert A; Klapper M; Döring F
    Biochem Biophys Res Commun; 2007 Feb; 353(2):481-6. PubMed ID: 17187763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between PGC-1alpha gene polymorphisms and type 2 diabetes risk: a case-control study of an Iranian population.
    Shokouhi S; Haghani K; Borji P; Bakhtiyari S
    Can J Diabetes; 2015 Feb; 39(1):65-72. PubMed ID: 25282005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.